Jafron Biomedical (China) Price Prediction
| 300529 Stock | 29.86 0.52 1.71% |
Oversold Vs Overbought
50
Oversold | Overbought |
Quarterly Earnings Growth 0.614 | EPS Estimate Current Year 1.17 | EPS Estimate Next Year 1.41 | Wall Street Target Price 38.205 | Quarterly Revenue Growth 0.477 |
Using Jafron Biomedical hype-based prediction, you can estimate the value of Jafron Biomedical Co from the perspective of Jafron Biomedical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Jafron Biomedical to buy its stock at a price that has no basis in reality. In that case, they are not buying Jafron because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Jafron Biomedical after-hype prediction price | CNY 29.86 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Jafron |
Jafron Biomedical After-Hype Price Prediction Density Analysis
As far as predicting the price of Jafron Biomedical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Jafron Biomedical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Jafron Biomedical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Jafron Biomedical Estimiated After-Hype Price Volatility
In the context of predicting Jafron Biomedical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Jafron Biomedical's historical news coverage. Jafron Biomedical's after-hype downside and upside margins for the prediction period are 25.80 and 33.92, respectively. We have considered Jafron Biomedical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Jafron Biomedical is not too volatile at this time. Analysis and calculation of next after-hype price of Jafron Biomedical is based on 3 months time horizon.
Jafron Biomedical Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Jafron Biomedical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Jafron Biomedical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Jafron Biomedical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.36 | 4.07 | 0.48 | 0.12 | 1 Events / Month | 1 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
29.86 | 29.86 | 1.71 |
|
Jafron Biomedical Hype Timeline
Jafron Biomedical is presently traded for 29.86on Shenzhen Stock Exchange of China. The entity has historical hype elasticity of -0.48, and average elasticity to hype of competition of -0.12. Jafron is forecasted to decline in value after the next headline, with the price expected to drop to 29.86. The average volatility of media hype impact on the company price is over 100%. The price decline on the next news is expected to be -1.71%, whereas the daily expected return is presently at 0.36%. The volatility of related hype on Jafron Biomedical is about 1212.91%, with the expected price after the next announcement by competition of 29.74. About 51.0% of the company shares are owned by insiders or employees . The company last dividend was issued on the 31st of May 2024. Jafron Biomedical had 1.9:1 split on the 20th of May 2020. Assuming the 90 days trading horizon the next forecasted press release will be very soon. Check out Jafron Biomedical Basic Forecasting Models to cross-verify your projections.Jafron Biomedical Related Hype Analysis
Having access to credible news sources related to Jafron Biomedical's direct competition is more important than ever and may enhance your ability to predict Jafron Biomedical's future price movements. Getting to know how Jafron Biomedical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Jafron Biomedical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 600519 | Kweichow Moutai Co | 0.00 | 0 per month | 1.84 | 0.01 | 6.55 | (2.98) | 16.71 | |
| 300750 | Contemporary Amperex Technology | 4.16 | 1 per month | 3.05 | 0.13 | 7.94 | (3.41) | 33.42 | |
| 603444 | G bits Network Technology | (4.18) | 1 per month | 3.16 | 0.06 | 5.21 | (4.79) | 18.75 | |
| 688169 | Beijing Roborock Technology | (2.92) | 1 per month | 4.12 | 0.01 | 5.74 | (5.72) | 34.80 | |
| 002594 | BYD Co Ltd | 0.45 | 2 per month | 1.93 | 0.07 | 5.74 | (3.34) | 14.84 | |
| 200596 | Anhui Gujing Distillery | 0.23 | 1 per month | 2.28 | 0.01 | 4.80 | (2.70) | 18.31 | |
| 000596 | Anhui Gujing Distillery | (1.01) | 1 per month | 2.90 | 0.03 | 9.98 | (4.36) | 20.00 | |
| 002371 | NAURA Technology Group | 0.25 | 2 per month | 2.18 | 0.11 | 9.80 | (3.99) | 15.93 | |
| 300760 | Shenzhen Mindray Bio Medical | 0.00 | 0 per month | 2.72 | 0.02 | 9.90 | (4.56) | 19.76 |
Jafron Biomedical Additional Predictive Modules
Most predictive techniques to examine Jafron price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Jafron using various technical indicators. When you analyze Jafron charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Jafron Biomedical Predictive Indicators
The successful prediction of Jafron Biomedical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Jafron Biomedical Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Jafron Biomedical based on analysis of Jafron Biomedical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Jafron Biomedical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Jafron Biomedical's related companies.
Story Coverage note for Jafron Biomedical
The number of cover stories for Jafron Biomedical depends on current market conditions and Jafron Biomedical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Jafron Biomedical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Jafron Biomedical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Jafron Biomedical Short Properties
Jafron Biomedical's future price predictability will typically decrease when Jafron Biomedical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Jafron Biomedical Co often depends not only on the future outlook of the potential Jafron Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Jafron Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 807.6 M |
Complementary Tools for Jafron Stock analysis
When running Jafron Biomedical's price analysis, check to measure Jafron Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jafron Biomedical is operating at the current time. Most of Jafron Biomedical's value examination focuses on studying past and present price action to predict the probability of Jafron Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jafron Biomedical's price. Additionally, you may evaluate how the addition of Jafron Biomedical to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |